The Evolving Treatment Landscape for Alzheimer’s

Regulators around the world have had differing receptions to new Alzheimer's drug candidates. Every year, Alzheimer’s Disease International marks September as Alzheimer’s Awareness Month, presenting an opportunity to challenge stigma, raise awareness and support those affected by Alzheimer’s disease around the world. In recent years, we have seen significant advances in the development of drugs to tackle Alzheimer’s, particularly in the wake of two decades of largely unfruitful research. Though some such treatments are being hailed as a success, not all researchers remain convinced. Regulators around the world have had differing receptions to the drugs, but despite their problems, research now seems to be trending in a positive direction.